UAMS Translational Research Institute

02/17/2026

Join TRI for a virtual Clinical Trials Learning Collaborative Seminar Series on Feb. 24

https://crisredcap.uams.edu/redcap/surveys/?s=LHREPYX8NAP3DM9D

TRI invites all UAMS-affiliated faculty to the next Clinical Trials Learning Collaborative Seminar Series on Feb. 24 from noon to 1 p.m., via Zoom.

Harry Selker, M.D., MSPH, professor at Tufts University School of Medicine and dean of Tufts' Clinical and Translational Science Institute, will present “Toward a Useful and Sustainable Role for N-of-1 Trials in Usual Clinical Care."

Selker’s research focuses on the development of treatment strategies aimed at improving medical care, including the development of "clinical predictive instruments," mathematical models that are used as decision aids. He has run large national clinical effectiveness trials and developed novel approaches in clinical study design and ex*****on, including the combination of efficacy and effectiveness trials and on the incorporation of N-of-1 trials into usual clinical practice.

02/13/2026

Register now for TRI's Research Day on April 9.

https://crisredcap.uams.edu/redcap/surveys/?s=XRRNRAPKCJM7FFAJ

The all-day event is focused on “Translational Science Principles in Action Across Arkansas" and will feature a keynote presentation at noon by nationally renowned scientist Barry Coller, M.D., from The Rockefeller University.

Other activities include translational science presentations, a poster session, and opportunities for networking. A detailed agenda will be sent to all registrants closer to the meeting date.

The event is 8:30 a.m. to 4:30 p.m. on April 9 in the Jo Ellen Ford Auditorium in the Donald W. Reynolds Institute on Aging. Meals for participants are included with advance registration.

Coller's keynote presentation is titled "From Monoclonal Antibody to Crystal Structure to Clinical Trial: The Zalunfiban (RUC-4) Story."

Coller is renowned for his investigations into the role of blood platelets and the mechanisms of blood cell adhesion in vascular disease. He is the David Rockefeller Professor of Medicine and co-principal investigator of the Rockefeller Clinical and Translational Science Award (CTSA).

02/12/2026

Cardiovascular disease is the No. 1 killer of women. Nearly 45% of women ages 20+ are living with some form of cardiovascular disease. Less than half of women entering pregnancy in the U.S. have optimal cardiovascular health. Women experience unique life stages, such as pregnancy and menopause, that can put them at an increased risk for CVD.

02/09/2026

Registration is open for the , scheduled for Saturday, May 2.

02/06/2026

✨𝐂. 𝐋𝐨𝐰𝐫𝐲 𝐁𝐚𝐫𝐧𝐞𝐬, 𝐌.𝐃., 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐂𝐡𝐚𝐧𝐜𝐞𝐥𝐥𝐨𝐫 𝐨𝐟 𝐔𝐀𝐌𝐒!🎉👏❤

MORE➡: https://bit.ly/46xTLLM

01/27/2026

Monica Smith, manager of regulatory affairs at the UAMS Translational Research Institute, recently received the 2025 Bonny Hope Wallace Award for her knowledge, leadership and compassion in conducting clinical trials.

01/22/2026

UAMS interim chancellor Dr. Lowry Barnes discusses several new initiatives involving urban and rural health.

01/15/2026

Please join us in congratulating Ashley Williams.
A doctoral student in our Health Promotion and Prevention Research program, Williams earned the 2025 UAMS Translational Research Institute Community Engaged Student/Trainee of the Year award for her work on the Brother Project.
The study focused on how income can impact health among Black men impacted by chronic illness.
In this photo, Williams (left) is at a Little Rock community event promoting the Brother Project.

09/26/2025

Join us for an important Lunch & Learn with the TRI Community Engagement team, the FAITH Network, and guest speaker Laura Kellams of Arkansas Advocates for Children and Families.

Although the flyer highlights faith leaders, everyone is welcome to attend this virtual discussion on upcoming SNAP and Medicaid changes. Bring your lunch and join the conversation!

07/30/2025

We’re proud to share our 2025 Annual Report, a magazine-style publication emphasizing the impact of translational science to improve lives in Arkansas and beyond. This year’s issue spotlights the researchers, programs and partnerships that are speeding the pace of discovery with meaningful health benefits.
The report includes examples of far-reaching research addressing unmet health needs, implementation of life-changing medical practices, and machine-learning and other advances to benefit rural health research.
Browse the magazine here: https://tinyurl.com/3k3ymj69

07/28/2025

UAMS postdoc Henry Palfrey, Ph.D., and the PulseArk Technologies team reached the semifinals and won Best Presentation at the global Bangkok Business Challenge!
Their device, VoluSense, detects internal bleeding earlier than current methods, a potential breakthrough in trauma care. Palfrey joined the team through TRI’s Health Sciences Innovation and Entrepreneurship (HSIE) Program, which prepares scientists to translate discoveries into real-world solutions.
Read how innovation training is preparing researchers to translate discoveries into clinical and commercial success: https://tinyurl.com/bdervbdb

Henry Palfrey, Ph.D., a postdoctoral fellow at the University of Arkansas for Medical Sciences (UAMS), and his business startup team, PulseArk Technologies, reached the semifinals and earned a Best Presentation Award in the Bangkok Business Challenge, one of the world’s leading student startup com...

06/12/2025

Researchers at UAMS want to better understand barriers to quitting smoking among Black menthol cigarette smokers in Arkansas. This research study includes 2 visits completed online or in-person, short daily smartphone surveys, and brief follow-up surveys.

Eligibility include Black/African American menthol cigarette smoker ages 21-75, be planning or willing to quit smoking in the next 30 days and have a smartphone.

Participants will be compensated for their time! Contact us for more information by calling (501) 526-6690, texting (501) 414-2060 or email UQuitstudy@uams.edu.

Visit our website for more information and to see if you are eligible. https://bit.ly/3Drpukr

About UQuit The UQuit research study was designed to help us learn more about the experience of quitting smoking among adults who smoke menthol ci******es and try to quit without professional assistance. The study will help us better understand how to improve smoking cessation among Black/African Am...